MedPath

Enhancing Recovery Capital Amid Opioid Use Disorder Pharmacotherapy: A Pilot Randomized Trial

Not Applicable
Not yet recruiting
Conditions
Opioid Use Disorder
Interventions
Behavioral: Recovery Community Center Linkage (RCCL)
Behavioral: Control Condition (CC)
Registration Number
NCT05245513
Lead Sponsor
Massachusetts General Hospital
Brief Summary

The aims of the current study are to: Aim 1. Develop and refine a novel intervention protocol for individuals receiving medication treatment for opioid use disorder that assertively links them to recovery community centers; Aim 2. Determine the feasibility, acceptability, and preliminary efficacy of assertive linkage to recovery community centers relative to a matched control condition, via a pilot randomized controlled trial; Aim 3. Explain quantitative findings by gaining an in-depth understanding of the intervention's feasibility, acceptability, and preliminary efficacy via qualitative interviews.

Detailed Description

This 5-year project seek to advance our understanding of the clinical and public health utility of recovery community centers and help bridge the gap between clinical treatment and community-based recovery support services. As a first step in this work, the investigators will develop and test a new intervention for peer-facilitated assertive linkage of patients receiving opioid use disorder pharmacotherapy to recovery community centers (RCCL), relative to a matched control condition (CC). This study aims to: Aim 1. Develop, manualize, and refine RCCL and CC protocols via stakeholder feedback. RCCL and CC protocols will be developed and manualized by adapting published community-based mutual-help linkage protocols. Upon preliminary manual development, feedback cycles will be conducted with relevant stakeholders (recovery coaches, recovery community center members, pharmacotherapy prescribers) to inform protocol revision, and promote its feasibility, acceptability, and adoptability. Aim 2. Determine the feasibility, acceptability, and preliminary efficacy of RCCL versus CC, via a pilot randomized controlled trial. More specifically, the feasibility of study procedures and RCCL/CC interventions, acceptability of interventions, and preliminary efficacy of RCCL relative to CC will be assessed. Aim 3. Explain quantitative findings by gaining an in-depth understanding of RCCL feasibility, acceptability, and efficacy via qualitative interviews in a subset of RCCL participants, peer facilitators, and linkage managers.

Recruitment & Eligibility

Status
NOT_YET_RECRUITING
Sex
All
Target Recruitment
145
Inclusion Criteria
  • age ≥ 18 years
  • past-year opioid use disorder diagnosis per the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition
  • currently undergoing outpatient buprenorphine treatment through a provider or program at Massachusetts General Hospital
  • current residence in Massachusetts
Exclusion Criteria
  • non-English fluency
  • active suicidality
  • neurodevelopmental disorders or neural trauma preventing informed consent
  • active psychosis
  • past-year attendance at a recovery community center or recovery support center

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Recovery Community Center Linkage (RCCL)Recovery Community Center Linkage (RCCL)The RCCL arm will involve a brief (\~20 minutes) meeting with a recovery coach (i.e. linkage manager), in which the recovery coach will inform the participant of recovery support services, including recovery community centers, and link them to a recovery community center, with the aid of a facilitated connection to a volunteer recovery community center member (i.e. peer facilitator). The linkage manager will also provide the participant with a list of recovery support service resources.
Control Condition (CC)Control Condition (CC)The CC arm will involve a time-matched meeting with a recovery coach (i.e. linkage manager), in which the recovery coach will broadly inform the participant of recovery support services, including recovery community centers, and provide them with a list of recovery support service resources.
Primary Outcome Measures
NameTimeMethod
Overall intervention acceptabilityMonth 1

Assessed via 1 single-item statement addressing the the acceptability of the intervention. The item is measured on a 6-point Likert scale (Strongly Disagree - Strongly Agree). Higher scores indicate greater acceptability.

Overall intervention satisfactionMonth 1

Assessed via the Client Satisfaction Questionnaire-8 (CSQ8) total score. This is an 8 item measure of client satisfaction with services. Total scores range from 8 to 32, with higher scores indicating greater satisfaction.

Recovery community center attendanceFrom the date of linkage manager meeting until the date of month-3 follow up, assessed up to 3 months

Percent of participants who attended a recovery community center 1+ time post linkage manager meeting, as assessed via the Timeline Follow Back

Overall intervention feasibilityFrom the date of intervention manual finalization until the date of study completion, assessed up to 48 months

Assessed via the Feasibility: Intervention Implementation \& Training scale average total score. This is a 2-item instrument to assess perceived intervention feasibility. Items are measured on a 6-point Likert scale (Strongly Disagree-Strongly Agree). Score is the calculated mean. Higher scores indicate greater feasibility.

Fidelity: Linkage manager adherenceFrom date of first linkage manager meeting until the date of last linkage manager meeting, assessed up to 36 months

Percent adherence of linkage managers to intervention protocols, as evaluated by the percentage of sessions that are scored with adequate adherence and assessed by recordings of intervention delivery and adherence evaluation materials developed as part of Aim 1 (e.g., adherence rating scales of critical topics). This is a 14-item instrument evaluating the extensiveness of linkage managers' delivery of critical intervention topics. Items are measured on a 5-point Likert scale (Not at all - Extensively). Score is the calculated mean. Total scores range from 1 to 5, with scores \> 3 indicating adequate adherence.

Use of recovery support servicesFrom the date of linkage manager meeting until the date of month-3 follow up, assessed up to 3 months

Percent days use of any recovery support services post linkage manager meeting, as assessed via the Timeline Follow Back

Overall recruitment feasibilityThrough study completion, ~3 years from recruitment initiation

Number of participants successfully recruited within allotted recruitment time frame (\~3 years)

Secondary Outcome Measures
NameTimeMethod
Intervention appropriatenessMonth 1

Assessed via the Intervention Appropriateness Measure (IAM; adapted for study parameters) average total score. This is a 4-item instrument to assess perceived intervention appropriateness. Items are measured on a 5-point Likert scale (Strongly Disagree-Strongly Agree). Score is the calculated mean. Higher scores indicate greater appropriateness.

Change in recovery capital from baseline to Month 3Baseline; Month 1; Month 3

Assessed via the REC-CAP Inventory total score. Scores range from -100 to +100, with higher scores indicating greater recovery capital.

Participant retentionFrom the date of first participant enrollment in the trial to the date of study completion, up to 42 months

Percent of enrolled participants who complete Month 3 Follow-Up

Feasibility of peer facilitator meet-upsMonth 1; Month 3

Percent of peer facilitator meet-ups occurring within 2 weeks of participant's linkage manager meeting

Intervention helpfulnessMonth 1; Month 3

Assessed via 4 single-item statements addressing the intervention's helpfulness in general and helpfulness to supporting treatment and opioid use disorder recovery. Items are measured on a 6-point Likert scale (Strongly Disagree-Strongly Agree). Score is the response for each item. Higher scores indicate greater helpfulness.

Trial Locations

Locations (1)

Massachusetts General Hospital

🇺🇸

Boston, Massachusetts, United States

© Copyright 2025. All Rights Reserved by MedPath